Kangbuk Samsung Hospital
Seoul, 03181, South Korea
NCT Number: NCT02609802
The aim of this clinical trial is to evaluate the difference of analgesic potency of sevoflurane and desflurane at equi-minimum alveolar concentration using a surgical pleth index.
Looking for future studies?
Notify Me19 year–65 year
All sexes
Interventional
Phase 3
Seoul, 03181, South Korea
Volatile anesthetics vary in their relative hypnotic potencies. Recent studies demonstrated that equi-minimum alveolar concentration of various volatile anesthetics produced different EEG-derived indices such as bispectral index. However, there was no controlled study that demonstrates the difference of analgesic potency. The aim of this clinical trial is to evaluate the difference of analgesic potency of sevoflurane and desflurane at equi-minimum alveolar concentration using a surgical pleth index.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Anesthesia was maintained with sevoflurane in patients undergoing arthroscopic shoulder surgery under general anesthesia and interscalene brachial plexus block.
Other names: SEVO
Anesthesia was maintained with desflurane in patients undergoing arthroscopic shoulder surgery under general anesthesia and interscalene brachial plexus block.
Other names: DES
Time frame: the first 60 min of maintaining a steady state 1 MAC of volatile agents
The analgesic potency was evaluated by surgical pleth index value
Kangbuk Samsung Hospital
Other
The Different Analgesic Potency of Sevoflurane and Desflurane at Equi-minimum Alveolar Concentration
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02221115
Musculoskeletal Diseases, Orthopedic Disorders
Montreal, Quebec, Canada
View Trial DetailsNCT02468934
Musculoskeletal Diseases, Neurologic Manifestations
La Jolla, California, United States
View Trial DetailsNCT02560155
Bacterial Infections, Bacterial Infections and Mycoses
Bern, Switzerland
View Trial DetailsNCT02814513
Central Motor Disorders, Musculoskeletal Diseases
Affoltern am Albis, Switzerland
View Trial Details